# Immuneering Corp: Form 8-K, filed Mar 14, 2024

- Company: [Immuneering Corp](/companies/imrx.md) (CIK 1790340)
- Form: 8-K
- Filed: 2024-03-14
- Accepted by EDGAR: Mar 14, 2024, 07:04 ET
- Period: 2024-03-11
- Accession: 0001104659-24-034204
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1790340/000110465924034204/tm248799d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1790340/000110465924034204/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1790340/000110465924034204/tm248799d1_8k.htm

Filed Mar 14, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-034204. Last ingested by Listed: Oct 29, 2026, 18:24 ET. No prices; not investment advice.